Back to search
FDAFDA · Food and drugs·Recall number D-1557-2014

Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05.

Published September 3, 2014 · Recall initiated: June 19, 2014

Summary

FDA records drug Class III recall D-1557-2014, published September 3, 2014 and initiated June 19, 2014. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2,658 Bottles; Lot: Lot 3040063 Exp. 07/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Lot 3040063 Exp. 07/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05. recalled?

Yes. FDA published recall D-1557-2014 on September 3, 2014. Reported hazard: Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone